drugset / Trial / NCT02039518

Study of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients

NCT02039518 ↗

Phase 2 Unknown 160 enrolled Fudan University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to Evaluate and compare safety and efficacy of Gemcitabine Maintenance Treatment in Patients With Extensive SCLC Patients Receiving Etoposide Combined With Platinum Based First-line Chemotherapy

Timeline

Start
2013-12
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule 1000 mg/m2 —